<DOC>
	<DOCNO>NCT01025258</DOCNO>
	<brief_summary>The purpose study assess impact collaborative active intervention program multi-disciplinary team improve adherence chronic medication improve clinical outcome CF patient .</brief_summary>
	<brief_title>Improving Adherence Clinical Outcome Cystic Fibrosis ( CF ) Patients</brief_title>
	<detailed_description>Cystic fibrosis life-threatening hereditary multi-system disease predominantly affect pancreas lung . Advances treatment lead significant improvement prognosis though depends crucially upon adherence treatment . It demonstrate chronic condition improve medication adherence improve clinical outcome , though difficult complex task . This first trial assess impact collaborative active intervention program multi disciplinary team improve adherence specific chronic medication improve clinical outcome CF patient . The trial divide two part : First Part The first part trial retrospective one data collect baseline , eligible patient file patient ' pharmacy record receive standard care past 12 month . Second Part The second part trial active interventional prospective one conduct 12 month . The active intervention compose series visit patient attend clinic every 2 month ( sooner , need ) specialize CF team member follow progress patient field expertise . Furthermore , frequent telephone call monitoring , educate identify barrier adherence make designated team member CF nurse CF clinical pharmacist . On identify problem concern medication adherence ( : difficulty receive medication sick fund , unwillingness inhale medication allegedly side effect , difficulty swallow pill , etc . ) solution suggest CF team member examine accordingly follow visit . Adherence specific chronic medication determine short self report questionnaire , structure interview clinical pharmacist prescription refill history obtain pharmacy record every visit clinical pharmacist . Outcomes measure patient 's hospital record baseline , 6 month 12 month start point . Measured clinical outcome : PFTs , number hospital admission , number exacerbation , number IV course , time exacerbation , inflammatory marker , BMI , HRQoL .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>1 . Patients diagnosis Cystic fibrosis age . 2 . CF patient treat one chronic medication : Tobi ( Tobramycin ) , Coliracin ( Colistin ) , Pulmozyme ( Dornase Alpha ) , Hypertonic Saline ( HS ) , Creon ( pancreatic enzyme ) , AquaADEKs ( Multivitamin ) . 3 . Patients willing participate trial . 4 . Presence parent/guardian capable providing inform consent . 5 . Patients attend CF clinic least every 12 month . 1 . Absence parent/guardian unwillingness provide permission . 2 . Potential participant decline provide assent . 3 . Transplant patient .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Cystic Fibrosis</keyword>
	<keyword>Medication Adherence</keyword>
	<keyword>Multidisciplinary Team</keyword>
	<keyword>Clinical Outcomes</keyword>
</DOC>